SCHEMBL7239347

SCHEMBL7239347

O=C(NC(CO)Cc1ccccc1)c1cccnc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 5/20 0.55
ROCK1 Q13464 5/20 0.55
MAPK1 P28482 3/20 0.55
PRKACA P17612 3/20 0.55
PRKX P51817 3/20 0.55
PRKG1 Q13976 3/20 0.55
CLK4 Q9HAZ1 3/20 0.55
RPS6KA5 O75582 2/20 0.55
RPS6KA4 O75676 2/20 0.55
GSK3B P49841 2/20 0.55
IRAK1 P51617 2/20 0.55
PKN2 Q16513 2/20 0.55
GSK3A P49840 1/20 0.55
SGK2 Q9HBY8 1/20 0.55
LIMK1 P53667 2/20 0.54
POLB P06746 1/20 0.51
ITGB2 P05107 1/20 0.51
ICAM1 P05362 1/20 0.51
ITGAL P20701 1/20 0.51
PDE10A Q9Y233 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7372990 0.80 CAPN1 (0.65) ROCK2ROCK1MAPK1PRKACAPRKX
SCHEMBL7787779 0.80 CAPN1 (0.65) ROCK2ROCK1MAPK1PRKACAPRKX
SCHEMBL28664069 0.80 ROCK2 (0.52) ROCK2ROCK1MAPK1PRKACAPRKX
SCHEMBL30255079 0.80 ROCK2 (0.60) ROCK2ROCK1MAPK1PRKACAPRKX
SCHEMBL31622393 0.80 ROCK2 (0.52) ROCK2ROCK1MAPK1PRKACAPRKX
SCHEMBL25406576 0.80 ROCK2 (0.60) ROCK2ROCK1MAPK1PRKACAPRKX
SCHEMBL7954435 0.79 EGLN1 (0.63) ROCK2ROCK1MAPK1PRKACAPRKX
SCHEMBL7954438 0.79 EGLN1 (0.63) ROCK2ROCK1MAPK1PRKACAPRKX
SCHEMBL14005607 0.79 MAPK1 (0.56) ROCK2ROCK1MAPK1PRKACAPRKX
SCHEMBL7242740 0.79 CAPN1 (0.57) ROCK2ROCK1MAPK1PRKACAPRKX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562827-B1 For the treatment of diseases in which increased calpain activity occurs such as neurodegenerative diseases or neuronal damage are caused by ischemia, trauma or mass hemorrhages ABBOTT LABORATORIES 2003-05-13 US disclosed
CN-1297441-A Heterocyclic substituted amides as calpain inhibitors BASF AG (DE) 2001-05-30 CN disclosed